Literature DB >> 8513603

The influence of donor age on function of renal allografts from live related donors.

N Sumrani1, P Daskalakis, A M Miles, J H Hong, B G Sommer.   

Abstract

To assess the influence of donor age on renal allograft outcome, we retrospectively analyzed all 169 consecutive cyclosporine-treated live related donor kidney transplants, of whom 40 were HLA identical siblings. All recipients were similar with respect to demographic and immunologic characteristics. Incidence of rejection episodes and graft survival rates at 1 and 5-year posttransplant were independent of donor age. Best renal function, as assessed by the mean of the lowest 3 serum creatinine concentration levels in the first 2 months posttransplant correlated positively with donor age, particularly among HLA mismatched male recipients (r = 0.4, P < 0.002). Short and intermediate term renal function was inferior, but stable in the older donor recipient group when compared to the younger cohort. Mean serum creatinine levels at 5 years in recipients of kidneys from older donors (age > 55 years) was 2.6 mg/dl compared to 1.7 and 1.9 mg/dl in recipients of kidneys from donors between the ages of 18-39 and 40-54 years, respectively (P < 0.001). In view of the universal shortage of organs and the negligible morbidity to the donors, our results should not discourage the use of kidneys from elderly (age > 55 years) donors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513603

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  High-risk donors: expanding donor criteria.

Authors:  M L Jordan; R Shapiro; C A Vivas; V P Scantlebury; R J Corry; P Randhawa; T R Hakala; T E Starzl
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Long-term follow-up of kidneys transplanted from elderly cadaveric donors.

Authors:  L M Wyner; A C Novick; E E Hodge; S M Flechner; B R Sankari; S B Streem
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 3.  Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?

Authors:  H U Meier-Kriesche; B Kaplan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.